About Ashley Simpson

Ashley Simpson is an attorney at Hoban Law Group. Ms. Simpson received her J. D. from Texas A&M University School of Law f/k/a Texas Wesleyan University School of Law in 2011.

FDA Issues Warning Letter to CBD Company for Fraudulent COVID-19 Treatment Claims

On Tuesday, the Food and Drug Administration (“FDA”) and the Federal Trade Commission (“FTC”) issued a Warning Letter issued to Neuro XPF, a company selling CBD products in the U.S., based on claims contained on its website and social media pages that its products can mitigate, prevent, treat, diagnose, or cure COVID-19. The FDA has

By |2020-04-03T15:12:28-06:00April 2nd, 2020|Government and Policy|

USDA Approves Texas Hemp Plan

This article is authored by Ashley Simpson with contributions from our law clerk, Haley Keefer.  In June of last year, Texas passed hemp legislation that authorizes the production, manufacture, retail sale, and inspection of hemp and hemp-derived products in Texas, including consumable hemp products that contain cannabidiol (“CBD”). Hemp is not currently legal to grow

By |2020-01-30T09:51:30-07:00January 30th, 2020|Government and Policy|

FDA and FTC Issue Joint Warning Letter

On Tuesday, the FDA and FTC issued another joint Warning Letter to a company for selling and marketing “unapproved new drugs” containing CBD in violation of federal law. Not surprisingly, the letter cites numerous disease claims included in the marketing of these products (e.g., statements related to the treatment of Parkinson’s and Alzheimer’s Disease, depression,

By |2019-12-18T13:03:22-07:00October 25th, 2019|Hemp|

Texas to Allow Additional Medical Cannabis Dispensary Applications

In 2015, Texas passed a law allowing a very limited group of patients in the state to obtain "low-THC cannabis" from licensed dispensaries pursuant to a doctor's prescription. This rather narrow law required the Texas Department of Public Safety (“DPS”) to create a secure registry of physicians who treat epilepsy for the purpose of prescribing

By |2019-12-18T12:17:58-07:00October 3rd, 2019|Government and Policy|

Concerns and Limitations for Multistate Producers Looking to Market CBD

Passage of the 2018 Farm Bill has undoubtedly provided comfort to large-scale retailers looking to bring hemp-derived products to retail shelves across the country. The language in the new law clarifies and affirms that hemp is not to be treated as a controlled substance as scheduled under the Controlled Substances Act of 1970 (CSA), which

By |2019-12-18T12:50:26-07:00April 2nd, 2019|Regulatory|

Medical Cannabis, Texas-Style: Conditions and Requirements for Use

By Ashley Simpson, Hoban Law Group In 2015, the Texas legislature’s passage of the Texas Compassionate Use Act (Senate Bill 339) legalized medical cannabis in the Lone Star State, but only to the extent of "low-THC cannabis oil" for use by patients diagnosed with intractable epilepsy. Widening further access to any patients respectively diagnosed with any other

By |2019-12-19T08:52:13-07:00March 27th, 2018|Government and Policy|